Nisha Rathode (Editor)

Peter Rheinstein

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
Nationality  US
Spouse  Miriam Rheinstein
Role  Physician

Name  Peter Rheinstein
Children  Jason Rheinstein
Peter Rheinstein httpslh4googleusercontentcomypBLKA7riEAAA
Born  September 7, 1943 (age 72) (1943-09-07) Cleveland, Ohio
Occupation  healthcare company executive, physician, lawyer
Known for  regulation of prescription drug promotion
Awards  Commendable Service award, Food and Drug Administration, 1981, Group award of merit, 1983, 1988, Group Commendable Service award, 1989, 1992—93, 1995, 1999, Commr.'s Special citation, 1993, American College of Legal Medicine Gold Medal (2003)

Education  Johns Hopkins University

Peter Howard Rheinstein (born September 7, 1943) is an American physician, lawyer, author, and administrator (both private and governmental). He was an official of the Food and Drug Administration (FDA) 1974-1999.

Contents

Education

Rheinstein received a B.A. with high honors from Michigan State University in 1963, an M.S. in mathematics from Michigan State University in 1964, an M.D. from Johns Hopkins University in 1967, and a J.D. from the University of Maryland School of Law in 1973. At Michigan State University Rheinstein was noted for his facility in mathematics.

Food and Drug Administration

Rheinstein was director of the Drug Advertising and Labeling Division, Food and Drug Administration, Rockville, 1974-1982; he was acting deputy director Office of Drugs, 1982–83, acting director Office of Drugs; 1983–84, director Office of Drug Standards, 1984–90, director medicine staff Office Health Affairs, 1990-99. While at FDA Rheinstein developed precedents for Food and Drug Administration regulation of prescription drug promotion, initiated FDA’s first patient medication information program; implemented the Drug Price Competition and Patent Term Restoration Act of 1984, and authored medication goals for Healthy People 2000 and 2010. Judy Woodruff interviewed Rheinstein about generic drug safety on the McNeil-Lehrer NewsHour.

Later career

From 1999 – 2004, Rheinstein was senior vice president for medical and clinical affairs, Cell Works, Inc., Baltimore. Among other projects, Cell Works wanted to develop a blood test for anthrax, similar to a system for cancer cells it produced. "It's something that companies like ours can incorporate into our diagnostic technology," Rheinstein told the Washington Times. Biodefense projects "create new technologies, the spin-offs of which can be commercialized into some pretty good things." In 2000 Rheinstein became president of Severn Health Solutions in Severna Park, Maryland. In 2010 Rheinstein was named president of the Academy of Physicians in Clinical Research and in 2011 was named chairman of the American Board of Legal Medicine. Rheinstein was named chairman of the United States Adopted Names Council in 2012. Rheinstein is a member of Phi Kappa Phi, and vice-president of the Intercultural Friends Foundation. Rheinstein is publisher of Discovery Medicine and chairman of MedData Foundation.

Publications

  • Co-author: Human Organ Transplantation: Societal, Medical-Legal, Regulatory, and Reimbursement Issues. Health Administration Press, Ann Arbor, Michigan 1987.
  • special editorial advisor, Good Housekeeping Guide to Medicines and Drugs, 1977–80
  • member editorial board Legal Aspects Medical Practice, 1981–89
  • member editorial board Drug Information Journal, 1982–86
  • publisher of Discovery Medicine, 2001-
  • References

    Peter Rheinstein Wikipedia


    Similar Topics
    Black Eye (film)
    Barnaby Phillips
    Wade Cunningham
    Topics
     
    B
    i
    Link
    H2
    L